News
About the PCSK9 Education and Research Forum
PCSK9 Education and Research Forum is the independent resource on PCSK9 science and its translation into critically important new treatments to lower low density lipoprotein cholesterol (LDL-C), which promise to transform the prognosis of millions of patients with hypercholesterolaemia (cholesterol disorders), accelerated atherosclerotic vascular heart disease and a high risk of premature cardiovascular (CV) death and disability.Aims & ObjectivesMission StatementEditorial BoardPartnership & OutreachForthcoming Meetings
Download Now: New Slide Deck Programme
Slide decks focusing on key results and expert analysis from FOURIER, ODYSSEY OUTCOMES and ODYSSEY trials – all landmark trials in PCSK9 inhibition.
Find out more »
ESC Congress 2019 with World Congress of Cardiology
31 August - 4 September, Paris, France
EVOPACS: Evolocumab in acute ACS
ORION-11 with inclisiran
LDL cholesterol goals go lower…
Hot Topics
Targeting the right patients for PCSK9 inhibition – ODYSSEY OUTCOMES offers new insights
How do clinicians ensure they gain the best value from PCSK9 inhibition in their very high-risk patients? New subgroup analyses from ODYSSEY OUTCOMES provide important insights.
Read the Report
Professor Gregory Schwartz (University of Colorado School of Medicine, Aurora, USA) discusses
Watch the Video
Professor Philippe Gabriel Steg (Assistance Publique-Hôpitaux de Paris, Paris, France) gives his view
Watch the Video
From the Editors
Are we doing any better with familial hypercholesterolaemia care?
Professor Eric Bruckert, Pitié-Salpêtrière Hospital, Paris, France
Has the care of this common inherited disorder, characterised by high cholesterol levels from birth, improved in the last 5 years? What can we learn from the only global registry?
Read the report
Insights from the EAS FHSC Registry, Prof. Eric Bruckert
Watch the video
Too little, too late: Prof. Raul Santos discusses the EAS FHSC Registry data
Watch the video
2019 ESC/EAS Dyslipidaemia Guidelines and FH, Prof. Eric Bruckert
Watch the video
Latest Views
Meet our Editorial Board
View all our Editorial Board
Prof John ChapmanResearch Professor at the University of Pierre and Marie Curie
Prof Henry GinsbergDirector, Irving Institute for Clinical and Translational Research
Dr Michel FarnierClinician based at Point Medical, Dijon, France
Prof Frederick RaalDirector, Carbohydrate & Lipid Metabolism Research Unit
Prof Anthony WierzbickiConsultant in Metabolic Medicine/Chemical Pathology
